Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2260971
Max Phase: Preclinical
Molecular Formula: C21H16N4O3
Molecular Weight: 372.38
Molecule Type: Small molecule
Associated Items:
ID: ALA2260971
Max Phase: Preclinical
Molecular Formula: C21H16N4O3
Molecular Weight: 372.38
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(OC(Cn1nnc2ccccc21)C(=O)c1ccccc1)c1ccncc1
Standard InChI: InChI=1S/C21H16N4O3/c26-20(15-6-2-1-3-7-15)19(28-21(27)16-10-12-22-13-11-16)14-25-18-9-5-4-8-17(18)23-24-25/h1-13,19H,14H2
Standard InChI Key: CLTMHRLGSQWDQW-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 372.38 | Molecular Weight (Monoisotopic): 372.1222 | AlogP: 2.93 | #Rotatable Bonds: 6 |
Polar Surface Area: 86.97 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.28 | CX Basic pKa: 3.40 | CX LogP: 3.46 | CX LogD: 3.46 |
Aromatic Rings: 4 | Heavy Atoms: 28 | QED Weighted: 0.38 | Np Likeness Score: -1.12 |
1. Wan J, Yan X, Ma C, Bi S, Zhu H. (2010) Synthesis, structure characterization, and biological evaluation of some new 1,2,3-benzotriazole derivatives, 19 (8): [10.1007/s00044-009-9243-3] |
Source(1):